Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Clinicians(Electronic Edition) ›› 2019, Vol. 13 ›› Issue (03): 209-213. doi: 10.3877/cma.j.issn.1674-0785.2019.03.011

Special Issue:

• Review • Previous Articles     Next Articles

Long noncoding RNA as biomarkers for tumors

Yuanyuan Du1,(), Peng Li1, Lingyan Song1, Xuxia Guo1   

  1. 1. Department of Clinical Laboratory, Heping Hospital Affiliated to Changzhi Medical College, Changzhi 046000, China
  • Received:2018-11-28 Online:2019-02-01 Published:2019-02-01
  • Contact: Yuanyuan Du
  • About author:
    Corresponding author: Du Yuanyuan, Email:

Abstract:

Long noncoding RNAs (LncRNAs) are a group of noncoding RNA molecules about 200 nt in length, which are involved in the regulation of various cell processes and associated with the development and progression of various cancer types. In recent years, detection of cancer-associated LncRNAs in body fluids of cancer patients has proven as an especially valuable method to effectively diagnose cancer. Compared to conventional tests, LncRNAs have great potential for routine usage in clinical practice due to their relative noninvasiveness. This review focuses on summarizing the perspectives of LncRNA as biomarkers in cancer, based on evaluating their expression profiles in body fluids of cancer patients.

Key words: Long non-coding RNA, Tumor, Biomarkers

京ICP 备07035254号-20
Copyright © Chinese Journal of Clinicians(Electronic Edition), All Rights Reserved.
Tel: 010-57830845 E-mail: zhlcyszz@cma.org.cn
Powered by Beijing Magtech Co. Ltd